Skip to main content
. 2018 Nov 29;103(6):1038–1044. doi: 10.1016/j.ajhg.2018.10.024

Table 1.

Biallelic POLE Mutations (GenBank: NM_006231.3)

ID Fam Sex Allele 1
Allele 2
Mat Allele Pat Allele Country of Origin
Nucleotide Change Amino Acid Consequence MAF Nucleotide Change Amino Acid Consequence MAF
P1 1 M c.2091dupC p.Phe699Valfs11 0 c.1686+32C>G p.Asn563Valfs16 0.000071 1 2 UK
P2 1 F c.2091dupC p.Phe699Valfs11 0 c.1686+32C>G p.Asn563Valfs16 0.000071 1 2 UK
P3 2 M c.62+1G>A Essential Splice Site Intron 1 0 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 Ireland
P4 3 F c.5940G>A p.Trp1980 0.000016 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 Australia
P5 4 M c.4728+1G>T Essential Splice Site Intron 36 0 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 USA
P6 5 F c.3264_3275+13del Essential Splice Site Intron 26 0.000016 c.1686+32C>G p.Asn563Valfs16 0.000071 1 2 Canada
P7 6 M c.1A>T p.? 0.000081 c.1686+32C>G p.Asn563Valfs16 0.000071 n/a n/a USA
P8 7 M c.1A>T p.? 0.000081 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 Ireland
P9 7 F c.1A>T p.? 0.000081 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 Ireland
P10 8 F c.3019G>C p.Ala1007Pro 0.000009 c.1686+32C>G p.Asn563Valfs16 0.000071 1 2 Ireland
P11 9 F c.5265delG Ile1756Serfs5 0 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 Australia
P12 9 M c.5265delG Ile1756Serfs5 0 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 Australia
P13 10 F c.2049C>G p.Tyr683 0.000028 c.1686+32C>G p.Asn563Valfs16 0.000071 1 2 Australia
P14 11 M c.6518_6519delCT p.Ser2173Phefs130 0.000089 c.1686+32C>G p.Asn563Valfs16 0.000071 2 1 USA
P15 12 M c.801+2T>C Essential Splice Site Intron 8 c.1686+32C>G p.Asn563Valfs16 0.000071 1 2 USA

Abbreviations: ID, individual number; Fam, family number; Mat, maternal; Pat, paternal; n/a, not available. All subjects harbored a loss-of-function mutation in combination with an intronic variant on the alternate allele identified as part of a shared haplotype and found to alter splicing in RNA studies. MAF indicates minor allele frequency in European (non-Finnish) population observed in gnomAD. None of the variants were present in any Non-European population in gnomAD.